Literature DB >> 24642075

The genetic basis of pheochromocytoma and paraganglioma: implications for management.

Brian Shuch1, Christopher J Ricketts1, Adam R Metwalli1, Karel Pacak2, W Marston Linehan3.   

Abstract

Chromaffin cells are catecholamine-producing cells derived from neural crest tissue. Chromaffin tumors are rare tumors arising from these cells and are divided into pheochromocytoma arising from adrenal tissue and paraganglioma arising from extra-adrenal ganglia. Previously, ∼10% were believed to be hereditary, but advances in genome sequencing have shown that roughly 35% of apparently sporadic tumors have a hereditary component. In this review, we describe both classic and newly discovered hereditary chromaffin tumors syndromes and provide recommendations for genetic testing. In many cases, the genes associated with these conditions are linked to common kidney cancer pathways familiar to urologic oncologists. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24642075      PMCID: PMC4572836          DOI: 10.1016/j.urology.2014.01.007

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  82 in total

1.  Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.

Authors:  Graeme Eisenhofer; Karel Pacak; Thanh-Truc Huynh; Nan Qin; Gennady Bratslavsky; W Marston Linehan; Massimo Mannelli; Peter Friberg; Stefan K Grebe; Henri J Timmers; Stefan R Bornstein; Jacques W M Lenders
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

2.  Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.

Authors:  Li Yao; Francesca Schiavi; Alberto Cascon; Yuejuan Qin; Lucia Inglada-Pérez; Elizabeth E King; Rodrigo A Toledo; Tonino Ercolino; Elena Rapizzi; Christopher J Ricketts; Luigi Mori; Mara Giacchè; Antonella Mendola; Elisa Taschin; Francesca Boaretto; Paola Loli; Maurizio Iacobone; Gian-Paolo Rossi; Bernadette Biondi; José Viana Lima-Junior; Claudio E Kater; Marie Bex; Miikka Vikkula; Ashley B Grossman; Stephen B Gruber; Marta Barontini; Alexandre Persu; Maurizio Castellano; Sergio P A Toledo; Eamonn R Maher; Massimo Mannelli; Giuseppe Opocher; Mercedes Robledo; Patricia L M Dahia
Journal:  JAMA       Date:  2010-12-15       Impact factor: 56.272

Review 3.  Preoperative management of the pheochromocytoma patient.

Authors:  Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2007-11       Impact factor: 5.958

4.  Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.

Authors:  Michael L Nickerson; Erich Jaeger; Yangu Shi; Jeffrey A Durocher; Sunil Mahurkar; David Zaridze; Vsevolod Matveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Anush Mukeria; Ivana Holcatova; Laura S Schmidt; Jorge R Toro; Sara Karami; Rayjean Hung; Gary F Gerard; W Marston Linehan; Maria Merino; Berton Zbar; Paolo Boffetta; Paul Brennan; Nathaniel Rothman; Wong-Ho Chow; Frederic M Waldman; Lee E Moore
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

5.  PHD2 mutation and congenital erythrocytosis with paraganglioma.

Authors:  Charline Ladroue; Romain Carcenac; Michel Leporrier; Sophie Gad; Claire Le Hello; Françoise Galateau-Salle; Jean Feunteun; Jacques Pouysségur; Stéphane Richard; Betty Gardie
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

6.  The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma.

Authors:  I S Mackenzie; M Gurnell; K K Balan; H Simpson; K Chatterjee; M J Brown
Journal:  Eur J Endocrinol       Date:  2007-10       Impact factor: 6.664

7.  The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.

Authors:  Susanne Schlisio; Rajappa S Kenchappa; Liesbeth C W Vredeveld; Rani E George; Rodney Stewart; Heidi Greulich; Kristina Shahriari; Nguyen V Nguyen; Pascal Pigny; Patricia L Dahia; Scott L Pomeroy; John M Maris; A Thomas Look; Matthew Meyerson; Daniel S Peeper; Bruce D Carter; William G Kaelin
Journal:  Genes Dev       Date:  2008-03-11       Impact factor: 11.361

8.  Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.

Authors:  Henri J L M Timmers; Karel Pacak; Thanh T Huynh; Mones Abu-Asab; Maria Tsokos; Maria J Merino; Bora E Baysal; Karen T Adams; Graeme Eisenhofer
Journal:  J Clin Endocrinol Metab       Date:  2008-10-07       Impact factor: 5.958

9.  A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors.

Authors:  I-Tien Yeh; Romina E Lenci; Yuejuan Qin; Kalyan Buddavarapu; Azra H Ligon; Emmanuelle Leteurtre; Christine Do Cao; Catherine Cardot-Bauters; Pascal Pigny; Patricia L M Dahia
Journal:  Hum Genet       Date:  2008-08-26       Impact factor: 4.132

10.  Germline SDHB mutations and familial renal cell carcinoma.

Authors:  Christopher Ricketts; Emma R Woodward; Pip Killick; Mark R Morris; Dewi Astuti; Farida Latif; Eamonn R Maher
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

View more
  13 in total

1.  Patterns of Use and Short-Term Outcomes of Minimally Invasive Surgery for Malignant Pheochromocytoma: A Population-Level Study.

Authors:  P Goffredo; M A Adam; S M Thomas; R P Scheri; J A Sosa; S A Roman
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

Review 2.  Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review.

Authors:  Rashmi Ramachandran; Vimi Rewari
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

3.  Malignant Vagal Paraganglioma.

Authors:  Erin R S Hamersley; Amy Barrows; Angel Perez; Ashley Schroeder; James T Castle
Journal:  Head Neck Pathol       Date:  2015-02-25

Review 4.  Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches.

Authors:  Marcia Helena Soares Costa; Tania M Ortiga-Carvalho; Alice Dutra Violante; Mario Vaisman
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-17       Impact factor: 5.555

5.  Screening for Hereditary Pheochromocytoma in a Patient with Neurofibromatosis Type 1: A Case Report.

Authors:  Inês Isabel Ferreira Barros; Fernando Manso; Ana Isabel Caldas E Silva; Maria Ramires Silva Lopes Pereira
Journal:  touchREV Endocrinol       Date:  2021-04-28

6.  Long term outcomes for patients with von Hippel-Lindau and Pheochromocytoma: defining the role of active surveillance.

Authors:  Thomas Sanford; Patrick T Gomella; Rashid Siddiqui; Daniel Su; Julie Y An; Gennady Bratslavsky; Mark W Ball; W Marston Linehan; Adam R Metwalli
Journal:  Urol Oncol       Date:  2020-12-08       Impact factor: 2.954

7.  Expression of Extracellular Signal-regulated Kinase 5 and Ankyrin Repeat Domain 1 in Composite Pheochromocytoma and Ganglioneuroblastoma Detected Incidentally in the Adult Adrenal Gland.

Authors:  Shinta Suenaga; Osamu Ichiyanagi; Hiromi Ito; Sei Naito; Tomoyuki Kato; Akira Nagaoka; Tomoya Kato; Mitsunori Yamakawa; Yutaro Obara; Norihiko Tsuchiya
Journal:  Intern Med       Date:  2016-12-15       Impact factor: 1.271

8.  Educational Case: Pheochromocytoma.

Authors:  Clinton Westover; Richard Michael Conran
Journal:  Acad Pathol       Date:  2018-08-23

Review 9.  The PI3K/Akt Pathway in Tumors of Endocrine Tissues.

Authors:  Helen Louise Robbins; Angela Hague
Journal:  Front Endocrinol (Lausanne)       Date:  2016-01-11       Impact factor: 5.555

Review 10.  A Clinical Roadmap to Investigate the Genetic Basis of Pediatric Pheochromocytoma: Which Genes Should Physicians Think About?

Authors:  Bernardo Dias Pereira; Tiago Nunes da Silva; Ana Teresa Bernardo; Rui César; Henrique Vara Luiz; Karel Pacak; Luísa Mota-Vieira
Journal:  Int J Endocrinol       Date:  2018-03-20       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.